中文名称: | KRAS inhibitor-9 一键复制产品信息 | ||||
---|---|---|---|---|---|
英文名称: | KRAS inhibitor-9 | ||||
别名: | KRAS inhibitor-9 4-(benzo[d]thiazol-2-ylthio)-3-chloroaniline;Cambridge id 5175303 | ||||
CAS No: | 300809-71-6 | 分子式: | C13H9ClN2S2 | 分子量: | 292.81 |
CAS No: | 300809-71-6 | ||||
分子式: | C13H9ClN2S2 | ||||
分子量: | 292.81 |
基本信息
产品编号: |
K10083 |
||||
产品名称: |
KRAS inhibitor-9 |
||||
CAS: |
300809-71-6 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
292.81 |
-20℃ |
1个月 |
||
化学名: |
STK764096;4-benzothiazol-2-ylthio-3-chlorophenylamine |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
'mg/mL |
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
3.4152mL |
17.0759mL |
34.1518mL |
5mM |
0.6830mL |
3.4152mL |
6.8304mL |
10mM |
0.3415mL |
1.7076mL |
3.4152mL |
生物活性
产品描述 |
是有效的 KRAS 抑制剂 (Kd=92μM),阻止 GTP-KRAS 的形成和 KRAS 下游激活。 |
||
靶点 |
Ras |
Apoptosis |
|
体外研究 |
KRAS inhibitor-9 bound to KRASG12D,KRAS G12C and KRAS Q61H protein with a moderate binding affinity of -5.38,-5.41,and -3.97 kcal/mol,respectively.KRAS inhibitor-9 (0-100μM) shows strong inhibition selectivity in NSCLC cells with IC50s ranging from 39.56 to 66.02μM for H2122,H358 and H460 cells (at 72 hours).KRAS inhibitor-9 (0-100μM;24 hours) blocks GTP-KRAS formation in H2122,H358 and H460 cells.KRAS inhibitor-9 (25-100μM;48 hours) inhibits the activation of KRAS downstream signaling pathway.KRAS inhibitor-9 (0-100μM;24-72 hours) induces cell cycle arrest and apoptosis in NSCLC. Cell Viability Assay |
||
Cell Line: |
H2122 (KRAS G12C),H358 (KRAS G12C) and H460 (KRAS Q61H) cell lines |
||
Concentration: |
0,25,50,100μM |
||
Incubation Time: |
24,48,and 72 hours |
||
Result: |
Inhibited three NSCLC cell lines in a dose- and time-dependent manner, but not in normal lung fibroblast cell line CCD-19Lu. |
||
Western Blot Analysis |
|||
Cell Line: |
H2122, H358 and H460 cells |
||
Concentration: |
0,25,50,100μM |
||
Incubation Time: |
48 hours |
||
Result: |
Reduces the levels of phosphorylation of CRAF and AKT in a dose-dependent manner in H2122, H358 and H460 cells. |
||
Apoptosis Analysis |
|||
Cell Line: |
H2122,H358,H460 cells |
||
Concentration: |
0,25,50,100μM |
||
Incubation Time: |
24-72 hours |
||
Result: |
Significantly decreased in G0/G1 phase while remarkably increased in G2/M phase after 24 hours and induced a significantly increased apoptosis for 48h in NSCLC cell lines. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )